Status:
TERMINATED
Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Society of Pediatric Urology
Conditions:
Vesicoureteral Reflux
Eligibility:
All Genders
2-6 years
Phase:
NA
Brief Summary
The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxie...
Eligibility Criteria
Inclusion
- Age 2-6 years
- Toilet trained
- English speaking
- Already scheduled for VCUG
Exclusion
- Allergic to midazolam
- Active UTI
- Known urethral stricture
- Known urethral reconstruction
- Has history of abnormal sensation in pelvic area
- Has history of sexual abuse
- Has severe developmental delay
- Has diagnosis of anxiety disorders
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00894465
Start Date
August 1 2006
End Date
August 1 2009
Last Update
December 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University
St Louis, Missouri, United States, 63110